Dean J Maccarter from 5884 Macon St, Englewood, CO 80111, Phone: 7205287404

Resumes

Chief Technology Officer

view source

Location:

Englewood, CO

Industry:

Medical Devices

Work:

Shape Medical Systems
Chief Technology Officer
Shape Medical Systems
Vice President Clinical Affairs at Shape Medical Systems

Us Patents

Use Of Ribose To Treat Fibromyalgia
view source
US Patent:

6703370, Mar 9, 2004
Filed:

Oct 26, 2000
Appl. No.:

09/697034
Inventors:

Terri L. Butler - Minneapolis MN
Dean J. MacCarter - Englewood CO
Daryl K. MacCarter - Eagle ID
Assignee:

Bioenergy, Inc. - Ham Lake MN
International Classification:

A01N 4304
US Classification:

514 23, 536 111
Abstract:

The present invention relates to methods and compositions comprising ribose for the treatment of fibromyalgia syndrome. The methods and compositions of the invention are especially suitable for oral administration and are useful for alleviating the symptoms of pain, fatigue, and irritable bowel syndrome in fibromyalgia syndrome.

Cardiopulmonary Monitoring
view source
US Patent:

6858006, Feb 22, 2005
Filed:

Sep 7, 2001
Appl. No.:

09/948997
Inventors:

Dean J. MacCarter - Englewood CO, US
Andreas N. Hadjicostis - Lone Tree CO, US
John K. Buckner - Littleton CO, US
Assignee:

Wireless Medical, Inc. - Englewood CO
International Classification:

A61B005/00
US Classification:

600300, 600301, 600538, 128903, 128904, 128920
Abstract:

According to the invention, a system for monitoring health information of a plurality of patients is disclosed. Included in the system are a data gathering device, a node, a wide area network, and a monitoring center. The data gathering device includes a respiration sensor, a wireless transmitter, and a self-contained power source. The node is wirelessly coupled to the data gathering device and the wide area network is coupled to the node. Located remote to the node, the monitoring center is coupled to the wide area network.

Use Of Ribose To Treat Fibromyalgia
view source
US Patent:

7094762, Aug 22, 2006
Filed:

Dec 27, 2003
Appl. No.:

10/745959
Inventors:

Terri L. Butler - Minneapolis MN, US
Dean J. MacCarter - Englewood CO, US
Daryl K. MacCarter - Eagle ID, US
Assignee:

Bioenergy, Inc. - Ham Lake MN
International Classification:

A01N 43/04
A61K 31/70
US Classification:

514 23, 536 111
Abstract:

The present invention relates to methods and compositions comprising ribose and maleate for the treatment of fibromyalgia syndrome. The methods and compositions of the invention are especially useful for oral administration and are useful for alleviating the symptoms of pain, fatigue, and irritable bowel syndrome in fibromyalgia syndrome.

Method Of Optimizing Patient Outcome From Cardiac Resynchronization Therapy
view source
US Patent:

7225022, May 29, 2007
Filed:

Mar 11, 2004
Appl. No.:

10/797948
Inventors:

Stephen T. Anderson - North Oaks MN, US
Dean J. MacCarter - Englewood CO, US
Assignee:

CRA Associates, Ltd. - North Oaks MN
International Classification:

A61N 1/365
US Classification:

607 18, 607 17, 607 19, 607 20, 607 23, 607 24
Abstract:

A method of data management for optimizing the patient outcome from the provision of cardiac resynchronization therapy (CRT) is described. This method describes a process by which sets of dynamic cardiopulmonary dependent variables are measured during steady-state conditions, displayed, and translated into quantitative and qualitative measurements while the independent variables of CRT, device lead placement and atrial-ventricular and interventricular delay settings of bi-ventricular pacemaker systems, are altered by a physician. In combination with visual observation and computer-assisted ranking of the dependent variables, a physician can utilize the resulting information to render decisions on the optimal choice of the independent variables.

Method Of Optimizing Patient Outcome From External Counterpulsation Therapy
view source
US Patent:

7713211, May 11, 2010
Filed:

Jul 12, 2004
Appl. No.:

10/889595
Inventors:

Stephen T. Anderson - North Oaks MN, US
Dean J. MacCarter - Englewood CO, US
Assignee:

Shape Medical Systems, Inc. - North Oaks MN
International Classification:

A61B 5/08
US Classification:

600484
Abstract:

A method of data management for optimizing the patient outcome from the provision of external counterpulsation (ECP) therapy is described. This method describes a process by which sets of dynamic cardiopulmonary dependent variables are measured during steady-state conditions, displayed, and translated into quantitative and qualitative measurements while the independent variables of ECP, cuff inflation duration and cuff inflation pressure settings of ECP systems, are altered by a physician. In combination with visual observation and computer-assisted ranking of the dependent variables, a physician can utilize the resulting information to render decisions on the optimal choice of the independent variables. The method will enable physicians to collect, view, track and manage complicated data using well-understood visualization techniques to better understand the consequences, acutely and chronically, of their therapeutic actions in general, and of their provision of ECP therapy in particular.

Method For Combining Individual Risk Variables Derived From Cardiopulmonary Exercise Testing Into A Single Variable
view source
US Patent:

8630811, Jan 14, 2014
Filed:

Jun 26, 2012
Appl. No.:

13/533519
Inventors:

Stephen T. Anderson - North Oaks MN, US
Dean J. MacCarter - Englewood CO, US
Bruce D. Johnson - Rochester MN, US
Assignee:

Shape Medical Systems, Inc. - St. Paul MN
International Classification:

G06F 19/00
A61B 5/08
US Classification:

702 19, 600529
Abstract:

A method of pattern recognition for classifying the functional status of patients with chronic disease comprising characterizing the functional status based on a multivariable index (MVI) scoring system wherein the MVI is computed by summing a plurality of individual variable values as individual variable indexes (IVI) and dividing the sum by the number of variables and wherein the plurality of IVI includes rest PetCO, ΔPetCO, SaO, QUES, V/VCOslope and Pand wherein each IVI is given an equivalent value of =4. 00, the number increasing with increasing severity yielding an MVI value ranging from =4. 00, normal to severe-very severe.

Method Of Cardiac Risk Assessment
view source
US Patent:

20030208106, Nov 6, 2003
Filed:

May 3, 2002
Appl. No.:

10/138442
Inventors:

Stephen Anderson - North Oaks MN, US
Dean MacCarter - Englewood CO, US
Assignee:

Cortex Biophysik GmbH - Leipzig
International Classification:

A61B005/00
US Classification:

600/300000
Abstract:

A method of data management for assessing a patient's autonomic balance, risk of death, and the patient's response to therapy in terms of these assessments is described. This method describes a process by which a set of “raw variables” (RV) are translated into one or more of a new variable, defined as an Autonomic Balance Index (ABI), that quantifies the patient's cardiovascular reflex control. The translated variables are representative of both central and peripheral chemo receptivity, baroreflexes, and peripheral ergo receptors, which, in turn, provide the measurement of sympathovagal, or autonomic, balance. The process of selection and measurement of the ABI, and thus the sympathetic and parasympathetic components of autonomic balance at rest and during dynamic, isotonic exercise and recovery is described. The invention will further define risk of death using a Kaplan-Meier Plot for certain translated variables. The method will enable physicians to collect, view, track and manage complicated data from multiple sources using simple, well-understood visualization techniques to better understand the consequences of their therapeutic actions.

Method Of Cardiac Risk Assessment
view source
US Patent:

20040260185, Dec 23, 2004
Filed:

Jul 12, 2004
Appl. No.:

10/891752
Inventors:

Stephen Anderson - North Oaks MN, US
Dean MacCarter - Englewood CO, US
Assignee:

Cortex Biophysik GmbH - Leipzig
International Classification:

A61B005/02
A61B005/00
A61B005/08
US Classification:

600/481000, 600/300000, 128/920000, 600/529000
Abstract:

A method of data management for assessing a patient's autonomic balance, risk of death, and the patient's response to therapy in terms of these assessments is described. This method describes a process by which a set of “raw variables” (RV) are translated into one or more of a new variable, defined as an Mortality Prediction Index, (MPI) that quantifies the patient's cardiovascular reflex control and risk of death. The translated variables are representative of both central and peripheral chemo receptivity, baroreflexes, and peripheral ergo receptors, which, in turn, provide the measurement of sympathovagal, or autonomic, balance. The process of selection and measurement of the MPI, and thus the sympathetic and parasympathetic components of autonomic balance at rest and during dynamic, isotonic exercise and recovery is described. The invention will further define risk of death using a Kaplan-Meier Plot for certain translated variables. The method will enable physicians to collect, view, track and manage complicated data from multiple sources using simple, well-understood visualization techniques to better understand the consequences of their therapeutic actions.